Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
REPH
|
Scp Vitalife Partners Ii LP
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 56,375 Reduced 2.62% |
$178,709
$3.17 p/Share
|
Dec 22
2020 |
|
REPH
|
Scp Vitalife Partners (Israel) Ii, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 18,830 Reduced 2.62% |
$59,691
$3.17 p/Share
|
Dec 22
2020 |
|
FIXX
|
5 Am Ventures Iv, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 500,000 Reduced 9.93% |
$6,410,000
$12.82 p/Share
|
Dec 22
2020 |
|
FIXX
|
Kush Parmar
Director |
SELL
Open market or private sale
|
Indirect | 500,000 Reduced 9.93% |
$6,410,000
$12.82 p/Share
|
Dec 22
2020 |
|
CLSK
|
Roger Paul Beynon |
BUY
Grant, award, or other acquisition
|
Direct | 740 Added 6.47% |
$7,496
$10.13 p/Share
|
Dec 22
2020 |
|
CLSK
|
Thomas Leigh Wood |
BUY
Grant, award, or other acquisition
|
Direct | 740 Added 1.33% |
$7,496
$10.13 p/Share
|
Dec 22
2020 |
|
IMMR
|
William C Martin
Chief Strategy Officer |
SELL
Open market or private sale
|
Indirect | 3,352 Reduced 0.09% |
$30,202
$9.01 p/Share
|
Dec 22
2020 |
|
STTK
|
Andrew R Neill
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 4,426 Added 4.45% |
$44
$0.01 p/Share
|
Dec 22
2020 |
|
LQDA
|
Eshelman Ventures, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 7,949 Reduced 0.12% |
$24,960
$3.14 p/Share
|
Dec 22
2020 |
|
FRBK
|
Harris Wildstein
Director |
SELL
Other acquisition or disposition
|
Indirect | 11,004 Reduced 36.57% |
-
|
Dec 22
2020 |
|
ACNB
|
David L Sites
Director |
BUY
Open market or private purchase
|
Direct | 1,461 Added 4.3% |
$36,525
$25.0 p/Share
|
Dec 22
2020 |
|
CYDY
|
Michael D. Mulholland
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 711,801 Reduced 71.47% |
$4,534,172
$6.37 p/Share
|
Dec 22
2020 |
|
CYDY
|
Michael D. Mulholland
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 711,801 Added 41.68% |
$761,627
$1.07 p/Share
|
Dec 22
2020 |
|
EVER
|
John Brandon Wagner
CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 3,559 Reduced 1.64% |
$138,623
$38.95 p/Share
|
Dec 22
2020 |
|
EVER
|
John Brandon Wagner
CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,559 Added 1.61% |
$24,486
$6.88 p/Share
|
Dec 22
2020 |
|
RPTX
|
Michael Zinda
EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct | 41,312 Reduced 32.65% |
$1,391,388
$33.68 p/Share
|
Dec 22
2020 |
|
RPTX
|
Michael Zinda
EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 41,312 Added 24.61% |
$76,427
$1.85 p/Share
|
Dec 22
2020 |
|
ASLE
|
Basil Barimo
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 32,372 Added 50.0% |
-
|
Dec 22
2020 |
|
ASLE
|
Nicholas Finazzo
Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 2,022,140 Added 34.91% |
$16,177,120
$8.0 p/Share
|
Dec 22
2020 |
|
ASLE
|
Martin Garmendia
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 4,730 Added 50.0% |
-
|
Dec 22
2020 |
|
ASLE
|
Iso Nezaj
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 24,200 Added 50.0% |
-
|
Dec 22
2020 |
|
ASLE
|
Robert B. Nichols
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 2,022,140 Added 34.91% |
$16,177,120
$8.0 p/Share
|
Dec 22
2020 |
|
ASLE
|
Peter J Nolan
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 26,050,506 Added 50.0% |
-
|
Dec 22
2020 |
|
ASLE
|
Frederick Craig Wright
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 24,493 Added 50.0% |
-
|
Dec 22
2020 |
|
ASLE
|
Sai S Devabhaktuni
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 32,500 Added 2.32% |
-
|
Dec 22
2020 |
|
ASLE
|
Sai S Devabhaktuni
Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 3,253,418 Reduced 70.89% |
-
|
Dec 22
2020 |
|
ASLE
|
Eric J Zahler
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 32,500 Added 2.32% |
-
|
Dec 22
2020 |
|
ASLE
|
Eric J Zahler
Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 3,253,418 Reduced 70.89% |
-
|
Dec 22
2020 |
|
ASLE
|
Richard J Townsend
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 32,500 Added 2.32% |
-
|
Dec 22
2020 |
|
ASLE
|
Richard J Townsend
Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 3,253,418 Reduced 70.89% |
-
|
Dec 22
2020 |
|
ASLE
|
Monocle Partners, LLC
> 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect | 32,500 Added 2.32% |
-
|
Dec 22
2020 |
|
ASLE
|
Monocle Partners, LLC
> 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 3,253,418 Reduced 70.89% |
-
|
Dec 22
2020 |
|
RNA
|
Troy Edward Wilson
Director |
BUY
Other acquisition or disposition
|
Indirect | 100,000 Added 50.0% |
-
|
Dec 22
2020 |
|
RNA
|
Troy Edward Wilson
Director |
SELL
Other acquisition or disposition
|
Direct | 100,000 Reduced 52.74% |
-
|
Dec 22
2020 |
|
CPRX
|
Richard J Daly
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,333 Added 50.0% |
-
|
Dec 22
2020 |
|
CPRX
|
Steve Miller
Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 2.87% |
-
|
Dec 22
2020 |
|
CPRX
|
Patrick J Mcenany
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 7,507 Reduced 0.16% |
-
|
Dec 22
2020 |
|
CPRX
|
Patrick J Mcenany
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 30,833 Added 0.64% |
-
|
Dec 22
2020 |
|
CPRX
|
Gary Ingenito
Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct | 3,668 Reduced 25.01% |
$12,655
$3.45 p/Share
|
Dec 22
2020 |
|
CPRX
|
Gary Ingenito
Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 14,666 Added 50.0% |
-
|
Dec 22
2020 |
|
CCRN
|
Thomas C Dircks
Director |
BUY
Bona fide gift
|
Indirect | 74,005 Added 50.0% |
-
|
Dec 22
2020 |
|
CCRN
|
Thomas C Dircks
Director |
SELL
Bona fide gift
|
Direct | 74,005 Reduced 40.44% |
-
|
Dec 22
2020 |
|
PRDO
|
Todd S Nelson
President and CEO |
SELL
Open market or private sale
|
Direct | 1,637 Reduced 0.19% |
$21,216
$12.96 p/Share
|
Dec 22
2020 |
|
REPL
|
Robert Coffin
Director |
SELL
Open market or private sale
|
Direct | 220,000 Reduced 10.87% |
$8,808,800
$40.04 p/Share
|
Dec 22
2020 |
|
PAYA
|
Christine E Larsen |
BUY
Grant, award, or other acquisition
|
Direct | 25,000 Added 50.0% |
-
|
Dec 22
2020 |
|
PAYA
|
Eric Christopher Bell
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 30,000 Added 50.0% |
-
|
Dec 22
2020 |
|
PAYA
|
Michael J Gordon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 25,000 Added 50.0% |
-
|
Dec 22
2020 |
|
CERS
|
Timothy B Anderson
Director |
SELL
Open market or private sale
|
Direct | 39,336 Reduced 16.38% |
$329,636
$8.38 p/Share
|
Dec 22
2020 |
|
CERS
|
Timothy B Anderson
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 30,000 Added 11.11% |
$162,000
$5.4 p/Share
|
Dec 22
2020 |
|
CERS
|
Chrystal Menard
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 211,327 Reduced 81.31% |
$1,690,616
$8.0 p/Share
|
Dec 22
2020 |